4.79
+0.39(+8.86%)
Currency In USD
| Previous Close | 4.4 |
| Open | 4.41 |
| Day High | 4.85 |
| Day Low | 4.33 |
| 52-Week High | 19.71 |
| 52-Week Low | 4.33 |
| Volume | 1.55M |
| Average Volume | 1.07M |
| Market Cap | 333.56M |
| PE | -0.91 |
| EPS | -5.29 |
| Moving Average 50 Days | 6.3 |
| Moving Average 200 Days | 11.23 |
| Change | 0.39 |
If you invested $1000 in Phathom Pharmaceuticals, Inc. (PHAT) since IPO date, it would be worth $194.72 as of March 12, 2025 at a share price of $4.79. Whereas If you bought $1000 worth of Phathom Pharmaceuticals, Inc. (PHAT) shares 5 years ago, it would be worth $157.51 as of March 12, 2025 at a share price of $4.79.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Phathom Pharmaceuticals to Report Fourth Quarter and Full Year 2024 Financial Results and Provide Business Update on Thursday, March 6, 2025
GlobeNewswire Inc.
Feb 24, 2025 1:00 PM GMT
Management to host conference call on Thursday, March 6, 2025, at 8:30 am ET FLORHAM PARK, N.J., Feb. 24, 2025 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing n
Phathom Pharmaceuticals to Present at the Guggenheim Securities SMID Cap Biotech Conference
GlobeNewswire Inc.
Jan 29, 2025 1:00 PM GMT
FLORHAM PARK, N.J., Jan. 29, 2025 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal (GI) diseases, announced today that memb
Phathom Pharmaceuticals Submits Citizen Petition to FDA Seeking Correction of Orange Book Listings for VOQUEZNA® (vonoprazan) Tablets
GlobeNewswire Inc.
Dec 11, 2024 1:00 PM GMT
Citizen Petition seeks correction of expiration date for New Chemical Entity (NCE) exclusivity on VOQUEZNA (vonoprazan) tablets Orange Book listingsPhathom believes applicable law mandates a 10-year NCE exclusivity period (from date of first approval